Ghent University Academic Bibliography

Advanced

Current and future use of the mannitol bronchial challenge in everyday clinical practice

Celeste Porsbjerg, Vibeke Backer, Guy Joos UGent, Huib AM Kerstjens and Roberto Rodriguez-Roisin (2009) CLINICAL RESPIRATORY JOURNAL. 3(4). p.189-197
abstract
Objectives: Asthma is a disease associated with inflammation, airway hyperresponsiveness (AHR) and airflow limitation. Clinical diagnosis and management of asthma often relies on assessment of lung function and symptom control, but these factors do not always correlate well with underlying inflammation. Bronchial challenge tests (BCTs) assess AHR, and can be used to assist in the diagnosis and management of asthma. Data Source: Data presented at the symposium 'Use of inhaled mannitol for assessing airways disease' organised by the Allied Respiratory Professionals Assembly (9) of the European Respiratory Society (ERS) at the ERS Congress, Berlin 2008. Results: Indirect challenge tests such as exercise testing, hypertonic saline or adenosine 5'-monophosphate (AMP) are more specific though less sensitive than direct challenge tests (such as methacholine) for identifying patients with active asthma. Indirect BCTs may be used to diagnose exercise-induced bronchoconstriction or AHR consistent with active asthma, to evaluate AHR that will respond to treatment with anti-inflammatory drugs and to determine the effectiveness and optimal dosing of such therapy. An ideal indirect challenge test should be standardised and reproducible, and the test result should correlate with the degree of airway inflammation. The mannitol BCT provides a standardised and rapid point-of-need test to identify currently active asthma, and is clinically useful in the identification of patients with asthma who are likely to benefit from inhaled corticosteroid therapy. Conclusion: In the future, mannitol BCT may be added to lung function and symptom assessment to aid in the everyday management of asthma. Please cite this paper as: Porsbjerg C, Backer V, Joos G, Kerstjens HAM and Rodriguez-Roisin R. Current and future use of the mannitol bronchial challenge in everyday clinical practice. The Clinical Respiratory Journal 2009; 3: 189-197.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
ASTHMATIC SUBJECTS, ADENOSINE-MONOPHOSPHATE, OBSTRUCTIVE PULMONARY-DISEASE, EXERCISE-INDUCED BRONCHOCONSTRICTION, AIRWAY HYPERRESPONSIVENESS, PROVOCATION TESTS, DRY POWDER, METHACHOLINE, INFLAMMATION, airway, asthma, bronchial, challenge, hyperresponsiveness, mannitol, INHALED CORTICOSTEROIDS
journal title
CLINICAL RESPIRATORY JOURNAL
Clin Respir J
volume
3
issue
4
pages
189 - 197
Web of Science type
Review
Web of Science id
000269903000002
JCR category
RESPIRATORY SYSTEM
JCR impact factor
0.597 (2009)
JCR rank
40/43 (2009)
JCR quartile
4 (2009)
ISSN
1752-6981
DOI
10.1111/j.1752-699x.2009.00161.x
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
889027
handle
http://hdl.handle.net/1854/LU-889027
date created
2010-03-03 16:06:18
date last changed
2015-06-17 11:23:14
@article{889027,
  abstract     = {Objectives: Asthma is a disease associated with inflammation, airway hyperresponsiveness (AHR) and airflow limitation. Clinical diagnosis and management of asthma often relies on assessment of lung function and symptom control, but these factors do not always correlate well with underlying inflammation. Bronchial challenge tests (BCTs) assess AHR, and can be used to assist in the diagnosis and management of asthma. Data Source: Data presented at the symposium 'Use of inhaled mannitol for assessing airways disease' organised by the Allied Respiratory Professionals Assembly (9) of the European Respiratory Society (ERS) at the ERS Congress, Berlin 2008. Results: Indirect challenge tests such as exercise testing, hypertonic saline or adenosine 5'-monophosphate (AMP) are more specific though less sensitive than direct challenge tests (such as methacholine) for identifying patients with active asthma. Indirect BCTs may be used to diagnose exercise-induced bronchoconstriction or AHR consistent with active asthma, to evaluate AHR that will respond to treatment with anti-inflammatory drugs and to determine the effectiveness and optimal dosing of such therapy. An ideal indirect challenge test should be standardised and reproducible, and the test result should correlate with the degree of airway inflammation. The mannitol BCT provides a standardised and rapid point-of-need test to identify currently active asthma, and is clinically useful in the identification of patients with asthma who are likely to benefit from inhaled corticosteroid therapy. Conclusion: In the future, mannitol BCT may be added to lung function and symptom assessment to aid in the everyday management of asthma. Please cite this paper as: Porsbjerg C, Backer V, Joos G, Kerstjens HAM and Rodriguez-Roisin R. Current and future use of the mannitol bronchial challenge in everyday clinical practice. The Clinical Respiratory Journal 2009; 3: 189-197.},
  author       = {Porsbjerg, Celeste and Backer, Vibeke and Joos, Guy and Kerstjens, Huib AM and Rodriguez-Roisin, Roberto},
  issn         = {1752-6981},
  journal      = {CLINICAL RESPIRATORY JOURNAL},
  keyword      = {ASTHMATIC SUBJECTS,ADENOSINE-MONOPHOSPHATE,OBSTRUCTIVE PULMONARY-DISEASE,EXERCISE-INDUCED BRONCHOCONSTRICTION,AIRWAY HYPERRESPONSIVENESS,PROVOCATION TESTS,DRY POWDER,METHACHOLINE,INFLAMMATION,airway,asthma,bronchial,challenge,hyperresponsiveness,mannitol,INHALED CORTICOSTEROIDS},
  language     = {eng},
  number       = {4},
  pages        = {189--197},
  title        = {Current and future use of the mannitol bronchial challenge in everyday clinical practice},
  url          = {http://dx.doi.org/10.1111/j.1752-699x.2009.00161.x},
  volume       = {3},
  year         = {2009},
}

Chicago
Porsbjerg, Celeste, Vibeke Backer, Guy Joos, Huib AM Kerstjens, and Roberto Rodriguez-Roisin. 2009. “Current and Future Use of the Mannitol Bronchial Challenge in Everyday Clinical Practice.” Clinical Respiratory Journal 3 (4): 189–197.
APA
Porsbjerg, C., Backer, V., Joos, G., Kerstjens, H. A., & Rodriguez-Roisin, R. (2009). Current and future use of the mannitol bronchial challenge in everyday clinical practice. CLINICAL RESPIRATORY JOURNAL, 3(4), 189–197.
Vancouver
1.
Porsbjerg C, Backer V, Joos G, Kerstjens HA, Rodriguez-Roisin R. Current and future use of the mannitol bronchial challenge in everyday clinical practice. CLINICAL RESPIRATORY JOURNAL. 2009;3(4):189–97.
MLA
Porsbjerg, Celeste, Vibeke Backer, Guy Joos, et al. “Current and Future Use of the Mannitol Bronchial Challenge in Everyday Clinical Practice.” CLINICAL RESPIRATORY JOURNAL 3.4 (2009): 189–197. Print.